VTN and Alzheimer disease: This has recently been shown to be a driver of Alzheimer’s disease pathogenesis [56] and our data revealing increased expression of several complement proteins at the ALS synapse, may suggest a similar process renders ALS synapses vulnerable to aberrant removal.